Skip to main content
Watch Insiders
QNRXHealthcare

Quoin Pharmaceuticals Ltd ADR (QNRX) Insider Trading

In the last 90 days, 4 Quoin Pharmaceuticals Ltd ADR (QNRX) insiders reported 4 open-market purchases totaling $279,966 and no sales. The most recent open-market purchase was reported on Aug 31, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
3
90-day purchase value
$279,966
Corporate buyers
4
Latest transaction
Aug 31, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 31, 2026Denise P. CarterChief Operating OfficerOpen Market Purchase20,490$4.88$99,991
Aug 31, 2026Michael MyersChief Executive OfficerOpen Market Purchase20,490$4.88$99,991
Aug 31, 2026Sally Bridget LawlorChief Financial OfficerOpen Market Purchase10,244$4.88$49,991
Aug 31, 2026Anthony James CulverwellCorporate insiderOpen Market Purchase6,146$4.88$29,992

Common questions

QNRX insider trading FAQ

Are QNRX insiders buying or selling?
Over the last 90 days, QNRX insiders were net buyers, reporting $279,966 of open-market purchases and $0.00 of sales.
When was the last QNRX insider purchase?
The most recent open-market purchase of Quoin Pharmaceuticals Ltd ADR stock by an insider was reported on Aug 31, 2026, one of 4 purchases in the last 90 days.
Where does QNRX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Quoin Pharmaceuticals Ltd ADR officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.